Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick N Cunningham

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Progress in Transplantation (Aliso Viejo, Calif.)|June 16, 2017
Patient-Reported Barriers to the Prekidney Transplant Evaluation in an At-Risk Population in the United StatesMark B Lockwood, Milda R Saunders, Rachel Nass, et al.
Transplantation|July 23, 2024
Efficacy and Safety of Bleselumab in Preventing the Recurrence of Primary Focal Segmental Glomerulosclerosis in Kidney Transplant Recipients: A Phase 2a, Randomized, Multicenter StudyJun Shoji, William C Goggins, Jason R Wellen, et al.
Human Molecular Genetics|May 31, 2013
Genetic and epigenetic variants contributing to clofarabine cytotoxicityMichael T Eadon, Heather E Wheeler, Amy L Stark, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2002
Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr miceLihua Bao, Mark Haas, Susan A Boackle, et al.
Kidney International|November 13, 2002
Decay-accelerating factor expression in the rat kidney is restricted to the apical surface of podocytesLihua Bao, O Brad Spiller, Patricia L St John, et al.
Plos One|September 19, 2019
Hypertensive APOL1 risk allele carriers demonstrate greater blood pressure reduction with angiotensin receptor blockade compared to low risk carriersPatrick N Cunningham, Zhiying Wang, Megan L Grove, et al.
International Journal of Molecular Sciences|March 25, 2017
Genetic Variants Contributing to Colistin Cytotoxicity: Identification of TGIF1 and HOXD10 Using a Population Genomics ApproachMichael T Eadon, Ronald J Hause, Amy L Stark, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Progress in Transplantation (Aliso Viejo, Calif.)|June 16, 2017
Patient-Reported Barriers to the Prekidney Transplant Evaluation in an At-Risk Population in the United StatesMark B Lockwood, Milda R Saunders, Rachel Nass, et al.
Transplantation|July 23, 2024
Efficacy and Safety of Bleselumab in Preventing the Recurrence of Primary Focal Segmental Glomerulosclerosis in Kidney Transplant Recipients: A Phase 2a, Randomized, Multicenter StudyJun Shoji, William C Goggins, Jason R Wellen, et al.
Human Molecular Genetics|May 31, 2013
Genetic and epigenetic variants contributing to clofarabine cytotoxicityMichael T Eadon, Heather E Wheeler, Amy L Stark, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2002
Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr miceLihua Bao, Mark Haas, Susan A Boackle, et al.
Kidney International|November 13, 2002
Decay-accelerating factor expression in the rat kidney is restricted to the apical surface of podocytesLihua Bao, O Brad Spiller, Patricia L St John, et al.
Plos One|September 19, 2019
Hypertensive APOL1 risk allele carriers demonstrate greater blood pressure reduction with angiotensin receptor blockade compared to low risk carriersPatrick N Cunningham, Zhiying Wang, Megan L Grove, et al.
International Journal of Molecular Sciences|March 25, 2017
Genetic Variants Contributing to Colistin Cytotoxicity: Identification of TGIF1 and HOXD10 Using a Population Genomics ApproachMichael T Eadon, Ronald J Hause, Amy L Stark, et al.
Pageof 3